Preoperative Colchicine and Conduction Disturbances After Transcatheter Aortic Valve Implantation: A US Retrospective Cohort Analysis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Preoperative colchicine use was linked to fewer conduction disturbances, such as atrioventricular block and left bundle-branch block, one month after transcatheter aortic valve intervention (TAVI). However, this protective effect diminished by six months post-TAVI.
Area Of Science
- Cardiology
- Pharmacology
- Medical Interventions
Background
- Conduction disturbances are common after transcatheter aortic valve intervention (TAVI).
- Inflammation is a suspected driver of these post-TAVI conduction issues.
- The impact of colchicine, an anti-inflammatory drug, on post-TAVI conduction disturbances remains unexamined.
Purpose Of The Study
- To investigate the association between preoperative colchicine use and the incidence of conduction disturbances following TAVI.
- To determine if colchicine influences the development or worsening of atrioventricular block or left bundle-branch block post-TAVI.
Main Methods
- A retrospective cohort study utilizing the TriNetX platform.
- Identified patients receiving colchicine within 3 months before TAVI, compared to propensity score-matched controls.
- Assessed new-onset or worsening atrioventricular block or left bundle-branch block at 1 and 6 months post-TAVI, with E-sensitivity analysis.
Main Results
- Out of 52,860 patients, 705 used preoperative colchicine; 702 were matched to controls.
- Colchicine use was associated with a significant reduction in atrioventricular block and left bundle-branch block at 1 month post-TAVI (P=0.041 and P=0.047).
- This significant association was not observed at 6 months post-TAVI (P=0.064 and P=0.109).
Conclusions
- Preoperative colchicine use demonstrated a protective association against conduction disturbances 1 month after TAVI.
- The observed benefit of colchicine on conduction disturbances did not persist at the 6-month follow-up.
- Further prospective research is warranted to confirm colchicine's definitive role in enhancing TAVI outcomes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...